Advertisement
Advertisement
RCUS
Arcus Biosciences, Inc.
21.64
USDSponsored
+0.60
+2.84%
Feb 02, 16:00 UTC -5
Closed
After-Market
21.64
+0.01
+0.04%
RCUS Earnings Reports
Positive Surprise Ratio
RCUS beat 17 of 31 last estimates.
55%
Next Report
Date of Next Report
Feb 25, 2026
Estimate for Q4 25 (Revenue/ EPS)
$36.99M
/-$1.04
Implied change from Q3 25 (Revenue/ EPS)
+42.28%
/-18.11%
Implied change from Q4 24 (Revenue/ EPS)
+42.28%
/+0.97%
Arcus Biosciences, Inc. earnings per share and revenue
On Oct 28, 2025, RCUS reported earnings of -1.27 USD per share (EPS) for Q3 25, beating the estimate of -1.33 USD, resulting in a 4.95% surprise. Revenue reached 26.00 million, compared to an expected 21.83 million, with a 19.11% difference. The market reacted with a +2.06% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analysts forecast an EPS of -1.04 USD, with revenue projected to reach 36.99 million USD, implying an decrease of -18.11% EPS, and increase of 42.28% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Twist Bioscience Corporation Common Stock
Report Date
Feb 02, 2026 For Q1 26
Estimate
-$0.43
Actual
-$0.50
Surprise
-14.00%
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
What were Arcus Biosciences, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Arcus Biosciences, Inc. reported EPS of -$1.27, beating estimates by 4.95%, and revenue of $26.00M, 19.11% above expectations.
How did the market react to Arcus Biosciences, Inc.'s Q3 2025 earnings?
The stock price moved up 2.06%, changed from $19.88 before the earnings release to $20.29 the day after.
When is Arcus Biosciences, Inc. expected to report next?
The next earning report is scheduled for Feb 25, 2026.
What are the forecasts for Arcus Biosciences, Inc.'s next earnings report?
Based on 12
analysts, Arcus Biosciences, Inc. is expected to report EPS of -$1.04 and revenue of $36.99M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement